Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$27,000.00

Investigating the role of the gut microbiome in promoting the virulence of Crohn’s disease-associated bacteria

EF 2024-25

Résumé
Crohn disease (CD) is a chronic inflammatory bowel disease with rampant incidence in Canada. Due to its unknown etiology, the current therapies are mostly symptomatic. Several groups have shown that CD-associated inflammation is driven by gut bacteria. In this regard, adherent-invasive strains of Escherichia coli (AIEC) have been found to expand during gut inflammation, and are more frequently isolated from CD patients compared to healthy individuals. These strains utilize a nanomachine called a type IV secretion system (T4SS) to aggregate on intestinal epithelial cells, forming structures called biofilms. These biofilms protect AIEC from external stressors such as antibiotics and immune cells, driving the persistence of these pathogens in the gut. We previously showed that AIEC strains overexpress T4SS in the gut environment. Building off these findings, I was able to show that host antimicrobial peptides (AMPs) activate T4SS expression and trigger biofilm formation. AMPs are produced by the host as a defense mechanism against gut pathogens. It is known that the gut microbiome influences AMP secretion. Notably, I found that AIEC displays minimal T4SS expression in germ-free mice. We thus propose that CD-associated microbiomes stimulate AMP secretion, promoting the formation of T4SS-mediated biofilms by AIEC. To test this, we will implant CD-associated and health-associated microbiomes in germ-free mice and infect them with AIEC. We will track T4SS expression by AIEC using established genetic and luminescent reporters. We will also track AMP expression and secretion in the different animal groups. This project will uncover mechanisms by which microbiomes of CD patients promote the pathogenesis of AIEC, allowing these bacteria to persist and drive gut inflammation.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
529906
Name
Lapa Natalie S
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of the gut microbiome in promoting the virulence of Crohn’s disease-associated bacteria
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bacteriology; Inflammatory Bowel Disease; Microbiology; Microbiome Studies; Molecular Biology
Abstract
Crohn disease (CD) is a chronic inflammatory bowel disease with rampant incidence in Canada. Due to its unknown etiology, the current therapies are mostly symptomatic. Several groups have shown that CD-associated inflammation is driven by gut bacteria. In this regard, adherent-invasive strains of Escherichia coli (AIEC) have been found to expand during gut inflammation, and are more frequently isolated from CD patients compared to healthy individuals. These strains utilize a nanomachine called a type IV secretion system (T4SS) to aggregate on intestinal epithelial cells, forming structures called biofilms. These biofilms protect AIEC from external stressors such as antibiotics and immune cells, driving the persistence of these pathogens in the gut. We previously showed that AIEC strains overexpress T4SS in the gut environment. Building off these findings, I was able to show that host antimicrobial peptides (AMPs) activate T4SS expression and trigger biofilm formation. AMPs are produced by the host as a defense mechanism against gut pathogens. It is known that the gut microbiome influences AMP secretion. Notably, I found that AIEC displays minimal T4SS expression in germ-free mice. We thus propose that CD-associated microbiomes stimulate AMP secretion, promoting the formation of T4SS-mediated biofilms by AIEC. To test this, we will implant CD-associated and health-associated microbiomes in germ-free mice and infect them with AIEC. We will track T4SS expression by AIEC using established genetic and luminescent reporters. We will also track AMP expression and secretion in the different animal groups. This project will uncover mechanisms by which microbiomes of CD patients promote the pathogenesis of AIEC, allowing these bacteria to persist and drive gut inflammation.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lapa, Natalie S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~